![Eric Shaff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eric Shaff
Amministratore Delegato presso SERES THERAPEUTICS, INC.
Patrimonio netto: 140 698 $ in data 31/07/2023
Profilo
Eric D.
Shaff is currently the President, Chief Executive Officer & Director at Seres Therapeutics, Inc. He previously served as an Independent Director at Sigilon Therapeutics, Inc. from 2017 to 2023.
Eric also worked as a Principal at Pfizer Inc. and as the Global Head-Rare Genetic Disease Finance at Genzyme Corp.
from 2004 to 2011.
He was the Vice President-Corporate Finance at Momenta Pharmaceuticals, Inc. from 2012 to 2014.
Prior to that, Eric worked as a Senior Analyst at Broadview International LLC.
He completed his undergraduate studies at the University of Pennsylvania and holds an MBA from the Johnson Graduate School of Management.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
SERES THERAPEUTICS INC
0.09% | 15/05/2024 | 140 698 ( 0.09% ) | 140 698 $ | 31/05/2024 |
11/08/2023 | 0 ( -.--% ) | - $ | 31/07/2023 |
Posizioni attive di Eric Shaff
Società | Posizione | Inizio |
---|---|---|
SERES THERAPEUTICS, INC. | Amministratore Delegato | 15/01/2019 |
Precedenti posizioni note di Eric Shaff
Società | Posizione | Fine |
---|---|---|
SIGILON THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 11/08/2023 |
MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/11/2014 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/12/2011 |
PFIZER, INC. | Corporate Officer/Principal | - |
Broadview International LLC
![]() Broadview International LLC Investment Banks/BrokersFinance Jefferies Broadview, a division of Jefferies & Company, Inc. provides services to the information technology, communications, healthcare technology and digital media industries. The firm addresses six major technology segments: communications technology, semiconductors and electronics manufacturing, enterprise software, digital media, and information technology services. Jefferies Broadview consists of 90 investment bankers operating in the US, Europe and Asia. The company provides investment banking services including debt and equity underwriting, private placements, M&A and restructuring advisory services. The company is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formazione di Eric Shaff
University of Pennsylvania | Undergraduate Degree |
Johnson Graduate School of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
SERES THERAPEUTICS, INC. | Health Technology |
PFIZER, INC. | Health Technology |
SIGILON THERAPEUTICS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Momenta Pharmaceuticals, Inc.
![]() Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Broadview International LLC
![]() Broadview International LLC Investment Banks/BrokersFinance Jefferies Broadview, a division of Jefferies & Company, Inc. provides services to the information technology, communications, healthcare technology and digital media industries. The firm addresses six major technology segments: communications technology, semiconductors and electronics manufacturing, enterprise software, digital media, and information technology services. Jefferies Broadview consists of 90 investment bankers operating in the US, Europe and Asia. The company provides investment banking services including debt and equity underwriting, private placements, M&A and restructuring advisory services. The company is headquartered in New York, NY. | Finance |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Eric Shaff